Sonoma Pharmaceuticals Inc (SNOA)
0.1569
-0.01
(-6.66%)
USD |
NASDAQ |
Apr 18, 16:00
0.1569
0.00 (0.00%)
After-Hours: 20:00
Sonoma Pharmaceuticals Cash from Financing (TTM): 4.426M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 4.426M |
September 30, 2023 | 2.79M |
June 30, 2023 | 2.741M |
March 31, 2023 | 2.489M |
December 31, 2022 | -0.661M |
September 30, 2022 | 0.12M |
June 30, 2022 | 7.218M |
March 31, 2022 | 7.396M |
December 31, 2021 | 7.443M |
September 30, 2021 | 7.222M |
June 30, 2021 | 0.515M |
March 31, 2021 | 3.308M |
December 31, 2020 | 3.039M |
September 30, 2020 | 4.067M |
June 30, 2020 | 3.749M |
March 31, 2020 | 1.029M |
December 31, 2019 | 0.949M |
September 30, 2019 | 4.576M |
June 30, 2019 | 4.562M |
March 31, 2019 | 5.492M |
December 31, 2018 | 10.01M |
September 30, 2018 | 6.007M |
June 30, 2018 | 6.06M |
March 31, 2018 | 5.24M |
December 31, 2017 | 0.889M |
Date | Value |
---|---|
September 30, 2017 | -0.024M |
June 30, 2017 | -0.01M |
March 31, 2017 | -0.032M |
December 31, 2016 | 3.044M |
September 30, 2016 | 4.012M |
June 30, 2016 | 5.164M |
March 31, 2016 | 6.039M |
December 31, 2015 | 8.535M |
September 30, 2015 | 7.462M |
June 30, 2015 | 6.567M |
March 31, 2015 | 6.609M |
December 31, 2014 | 4.50M |
September 30, 2014 | 5.937M |
June 30, 2014 | 5.071M |
March 31, 2014 | 2.945M |
December 31, 2013 | 1.84M |
September 30, 2013 | -0.042M |
June 30, 2013 | 0.128M |
March 31, 2013 | 3.75M |
December 31, 2012 | 1.173M |
September 30, 2012 | 4.374M |
June 30, 2012 | 4.555M |
March 31, 2012 | 3.449M |
December 31, 2011 | 3.438M |
September 30, 2011 | 1.765M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-0.661M
Minimum
Dec 2022
7.443M
Maximum
Dec 2021
3.525M
Average
3.308M
Median
Mar 2021
Cash from Financing (TTM) Benchmarks
NovaBay Pharmaceuticals Inc | 1.91M |
Palatin Technologies Inc | 5.553M |
iBio Inc | 10.68M |
Theriva Biologics Inc | 0.625M |
Ampio Pharmaceuticals Inc | 0.00 |